Logo image of MAGN

MAGNERA CORP (MAGN) Stock Fundamental Analysis

NYSE:MAGN - New York Stock Exchange, Inc. - US55939A1079 - Common Stock - Currency: USD

21.44  -0.32 (-1.47%)

After market: 21.44 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MAGN. MAGN was compared to 9 industry peers in the Paper & Forest Products industry. MAGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MAGN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MAGN has reported negative net income.
In the past year MAGN had a positive cash flow from operations.
In multiple years MAGN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MAGN reported negative operating cash flow in multiple years.
MAGN Yearly Net Income VS EBIT VS OCF VS FCFMAGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.37%, MAGN is in line with its industry, outperforming 44.44% of the companies in the same industry.
MAGN's Return On Equity of -32.19% is on the low side compared to the rest of the industry. MAGN is outperformed by 66.67% of its industry peers.
MAGN has a Return On Invested Capital (0.87%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for MAGN is significantly below the industry average of 6.65%.
Industry RankSector Rank
ROA -4.37%
ROE -32.19%
ROIC 0.87%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
MAGN Yearly ROA, ROE, ROICMAGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

MAGN's Operating Margin of 1.07% is on the low side compared to the rest of the industry. MAGN is outperformed by 66.67% of its industry peers.
In the last couple of years the Operating Margin of MAGN has declined.
MAGN has a Gross Margin of 10.51%. This is comparable to the rest of the industry: MAGN outperforms 44.44% of its industry peers.
In the last couple of years the Gross Margin of MAGN has declined.
Industry RankSector Rank
OM 1.07%
PM (TTM) N/A
GM 10.51%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
MAGN Yearly Profit, Operating, Gross MarginsMAGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MAGN is destroying value.
The number of shares outstanding for MAGN has been reduced compared to 1 year ago.
The number of shares outstanding for MAGN has been reduced compared to 5 years ago.
Compared to 1 year ago, MAGN has a worse debt to assets ratio.
MAGN Yearly Shares OutstandingMAGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAGN Yearly Total Debt VS Total AssetsMAGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

MAGN has an Altman-Z score of 1.83. This is not the best score and indicates that MAGN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.83, MAGN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 4.29 is on the high side and indicates that MAGN has dependencies on debt financing.
The Debt to Equity ratio of MAGN (4.29) is worse than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.29
Debt/FCF N/A
Altman-Z 1.83
ROIC/WACC0.11
WACC7.8%
MAGN Yearly LT Debt VS Equity VS FCFMAGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

MAGN has a Current Ratio of 2.23. This indicates that MAGN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.23, MAGN is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
MAGN has a Quick Ratio of 1.04. This is a normal value and indicates that MAGN is financially healthy and should not expect problems in meeting its short term obligations.
MAGN has a Quick ratio of 1.04. This is in the lower half of the industry: MAGN underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.04
MAGN Yearly Current Assets VS Current LiabilitesMAGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

The earnings per share for MAGN have decreased strongly by -93.18% in the last year.
Looking at the last year, MAGN shows a decrease in Revenue. The Revenue has decreased by -9.02% in the last year.
Measured over the past years, MAGN shows a quite strong growth in Revenue. The Revenue has been growing by 9.85% on average per year.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-913.95%
Revenue 1Y (TTM)-9.02%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%0.67%

3.2 Future

MAGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.17% yearly.
The Revenue is expected to grow by 22.15% on average over the next years. This is a very strong growth
EPS Next Y-14%
EPS Next 2Y-22.96%
EPS Next 3Y47.55%
EPS Next 5Y40.17%
Revenue Next Year120.68%
Revenue Next 2Y44.94%
Revenue Next 3Y29.89%
Revenue Next 5Y22.15%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAGN Yearly Revenue VS EstimatesMAGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
MAGN Yearly EPS VS EstimatesMAGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MAGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAGN Price Earnings VS Forward Price EarningsMAGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAGN is valued a bit more expensive than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.75
MAGN Per share dataMAGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as MAGN's earnings are expected to grow with 47.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.96%
EPS Next 3Y47.55%

0

5. Dividend

5.1 Amount

MAGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAGNERA CORP

NYSE:MAGN (2/21/2025, 8:04:01 PM)

After market: 21.44 0 (0%)

21.44

-0.32 (-1.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)02-20 2025-02-20
Earnings (Next)08-06 2025-08-06
Inst Owners93.54%
Inst Owner Change24406.8%
Ins Owners0.38%
Ins Owner Change59.11%
Market Cap758.98M
Analysts82.86
Price Target24.48 (14.18%)
Short Float %6.62%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF 104.2
P/B 3.67
P/tB N/A
EV/EBITDA 20.75
EPS(TTM)-0.85
EYN/A
EPS(NY)-1.29
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)0.21
OCFY0.96%
SpS36.98
BVpS5.84
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.37%
ROE -32.19%
ROCE 1.11%
ROIC 0.87%
ROICexc 0.9%
ROICexgc 1.09%
OM 1.07%
PM (TTM) N/A
GM 10.51%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.77%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexcg growth 3Y-33.98%
ROICexcg growth 5Y-5.57%
ROICexc growth 3Y-31.54%
ROICexc growth 5Y-3.54%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
F-Score4
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 4.29
Debt/FCF N/A
Debt/EBITDA 11.53
Cap/Depr 48.06%
Cap/Sales 2.31%
Interest Coverage 0.21
Cash Conversion 9.46%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.04
Altman-Z 1.83
F-Score4
WACC7.8%
ROIC/WACC0.11
Cap/Depr(3y)52.93%
Cap/Depr(5y)52.63%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-913.95%
EPS Next Y-14%
EPS Next 2Y-22.96%
EPS Next 3Y47.55%
EPS Next 5Y40.17%
Revenue 1Y (TTM)-9.02%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%0.67%
Revenue Next Year120.68%
Revenue Next 2Y44.94%
Revenue Next 3Y29.89%
Revenue Next 5Y22.15%
EBIT growth 1Y-37.96%
EBIT growth 3Y-25.3%
EBIT growth 5Y1.43%
EBIT Next Year515.25%
EBIT Next 3Y90.67%
EBIT Next 5YN/A
FCF growth 1Y68.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y122.55%
OCF growth 3YN/A
OCF growth 5YN/A